Recombinant Influenza Vaccination in U.S. Nursing Homes

Clinical trial NCT03965195 · UNKNOWN

Trial details

NCT number: NCT03965195
Sponsor: Insight Therapeutics, LLC
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza Influenza -Like Illness Influenza, Human

Start date: 2019-07-20
Primary completion: 2023-08-01
Enrollment: 1989

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.